Roche follows Shire to Europe with hemophilia recommendation for Hemlibra

Roche and Shire are taking their hemophilia battle across the pond. Following Shire’s EU approval for Adynovi last week, Roche has nabbed a European approval recommendation for Hemlibra, a first-in-class hemophilia A medication that analysts expect to reach blockbuster heights.Original Article